Form 4 for ACH ACCENDRA HEALTH INC/VA/

Accepted 2022-05-03 00:00:00 ET · period of report 2022-04-29 · accession 0001062993-22-011322 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-05-03	2022-05-02	ACH	Henkel Robert J	Dir	P - Purchase	$35.00	+2,000	26.0K	+8%	+$70.0K
DM	2022-05-03	2022-04-29	ACH	Henkel Robert J	Dir	A - Grant	$0.0072	+4,932	47.0K	+12%	+$35.49

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-05-02	P	A	2,000	$35.00	26,000	D	—	—	(F1) The purchase of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 30, 2020.
2	Derivative	Phantom Stock	2022-04-29	A	A	1	$35.49	42,070	D	— · — to —	1 Common Stock	(F3) Shares acquired through quarterly dividend reinvestment transaction. (F2) The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).
3	Derivative	Phantom Stock	2022-04-29	A	A	4,931	$0.00	47,001	D	— · — to —	4,931 Common Stock	(F2) The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).